ArticleWorld journal of urology2025

Updated cost-effectiveness analysis of first-line novel therapies in locally advanced or metastatic urothelial carcinoma across the UK, US, and China.

Jingwen Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.